ECB’s Schnabel Says Trump’s Onslaught May Mark End of Free Trade

Source: Bloomberg, 11:22

“We didn’t start Model to launch a company — we started it because no one else met our standards,” says Dr. Daniel Haders II, CEO and founder of Model Medicines. On this episode of Vanguards of Health Care, Haders speaks with Bloomberg Intelligence analyst Andrew Galler about building an AI-native drug discovery engine capable of identifying cryptic binding pockets and designing first-in-class drugs. They unpack why hit rates and novelty must go hand-in-hand, an overview of the company’s pan-ant

John Bozzella, President & CEO of the Alliance for Automotive Innovation, states that prices will go up and volume will come down when sharing his thoughts on President Trump announcing 25% auto tariffs last week along with additional tariffs on steel & aluminum. Bozzella talks about how the President’s tariffs may impact car companies wanting to create factories in the United States, and if companies will eventually decide not to sell in America. Bozzella speaks with Kailey Leinz and Joe Mathieu on Bloomberg’s “Balance of Power: Late Edition.” (Source: Bloomberg)